Issues related to the U.S. Patent Office, federal grants, de-extinction, and regulatory landscape of synthetic biology.
2026 · 2nd Quarter (Apr 1 - June 30)
COLOSSAL BIOSCIENCES INC.
Filed by MILLER STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- MILLER STRATEGIES, LLC
- Filing UUID
- 209c3346-d032-45c3-a509-0e93cef6efe0
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to the U.S. Patent Office, federal grants, de-extinction, and regulatory landscape of synthetic biology.
Issues related to the U.S. Patent Office, federal grants, de-extinction, and regulatory landscape of synthetic biology.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.